Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?-Reference-Cited by-同舟云学术

Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?

Published:2017-02-21 Issue:4 Volume:28 Page:299-308
ISSN:0957-5243
Container-title:Cancer Causes & Control
language:en
Short-container-title:Cancer Causes Control

Author:

Subramanian Sujha,Bobashev Georgiy,Morris Robert J.,Hoover Sonja

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10552-017-0864-4.pdf

Reference35 articles.

1. U.S. Cancer Statistics Working Group (2014) United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. 2014 http://www.cdc.gov/uscs

2. National Colorectal Cancer Roundtable (2015) 80% screening rate by 2018. http://nccrt.org/tools/80-percent-by-2018 . Accessed 22 Aug 2015

3. Knudsen AB, Zauber AG, Rutter CM et al (2016) Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. JAMA 315(23):2595–2609. doi: 10.1001/jama.2016.68282529493

4. Bibbins-Domingo K, Grossman DC, Curry SJ et al (2016) Screening for colorectal cancer: us preventive services task force recommendation statement. JAMA 315(23):2564–2575. doi: 10.1001/jama.2016.59892529486

5. Lin JS, Piper MA, Perdue LA et al (2016) Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force. JAMA 315(23):2576–2594. doi: 10.1001/jama.2016.33322529492

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer;Cell Death & Disease;2024-05-10

2. Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer;2024-01-10

3. Risk-Stratified Screening for Colorectal Cancer Using Genetic and Environmental Risk Factors: A Cost-Effectiveness Analysis Based on Real-World Data;Clinical Gastroenterology and Hepatology;2023-12

4. Cost‐effectiveness of risk‐tailored screening strategy for colorectal cancer: A systematic review;Journal of Gastroenterology and Hepatology;2022-04-25

5. A scoping review of risk-stratified bowel screening: current evidence, future directions;Cancer Causes & Control;2022-03-20